Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Clinical trial NCT01374906 · COMPLETED
Trial details
- NCT number
- NCT01374906
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-04
- Primary completion
- 2016-12-21
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.